Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2012

01-08-2012 | Letter To the Editor

Breast fat and breast cancer

Authors: Andreas Pettersson, Rulla M. Tamimi

Published in: Breast Cancer Research and Treatment | Issue 1/2012

Login to get access

Excerpt

There is a well-established association between high mammographic density and risk of breast cancer. We recently observed, somewhat to our surprise, a strong inverse association between the nondense area on a mammogram and risk of breast cancer [1]. In this article, we briefly discuss this finding in the context of previous studies of mammographic density and breast cancer risk, as well as in context of prior findings of the association between excess body weight and breast cancer risk. We suggest that the notion that breast fat plays a protective role in breast carcinogenesis, at least during the premenopausal years, should be considered. …
Literature
1.
Pettersson A, Hankinson SE, Willett WC, Lagiou P, Trichopoulos D, Tamimi RM (2011) Nondense mammographic area and risk of breast cancer. Breast Cancer Res 13(5):R100PubMedCrossRef
2.
Byrne C, Schairer C, Wolfe J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622–1629PubMedCrossRef
3.
McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159–1169PubMedCrossRef
4.
Trichopoulos D, Lipman RD (1992) Mammary gland mass and breast cancer risk. Epidemiology 3(6):523–526PubMedCrossRef
5.
Stuedal A, Ma H, Bernstein L, Pike MC, Ursin G (2008) Does breast size modify the association between mammographic density and breast cancer risk? Cancer Epidemiol Biomarkers Prev 17(3):621–627PubMedCrossRef
6.
Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH (2011) Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res 13(5):R103PubMedCrossRef
7.
Stone J, Ding J, Warren RM, Duffy SW, Hopper JL (2010) Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res 12(6):R97
8.
Torres-Mejia G, De Stavola B, Allen DS et al (2005) Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 14(5):1052–1059PubMedCrossRef
9.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578PubMedCrossRef
10.
Key TJ, Appleby PN, Reeves GK et al (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16):1218–1226PubMedCrossRef
11.
Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66(1):33–38PubMedCrossRef
12.
Boyd NF, Martin LJ, Sun L et al (2006) Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(11):2086–2092PubMedCrossRef
13.
Harris HR, Tamimi RM, Willett WC, Hankinson SE, Michels KB (2011) Body size across the life course, mammographic density, and risk of breast cancer. Am J Epidemiol 174(8):909–918PubMedCrossRef
14.
Hovey RC, Aimo L (2010) Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia 15(3):279–290PubMedCrossRef
15.
Ching S, Kashinkunti S, Niehaus MD, Zinser GM (2011) Mammary adipocytes bioactivate 25-hydroxyvitamin D and signal via vitamin D receptor, modulating mammary epithelial cell growth. J Cell Biochem 112(11):3393–3405PubMedCrossRef
16.
Beer AE, Billingham RE (1978) Adipose tissue, a neglected factor in aetiology of breast cancer? Lancet 2(8084):296PubMedCrossRef
17.
Levental KR, Yu H, Kass L et al (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5):891–906PubMedCrossRef
18.
Paszek MJ, Zahir N, Johnson KR et al (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8(3):241–254PubMedCrossRef
19.
Provenzano PP, Inman DR, Eliceiri KW, Keely PJ (2009) Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28(49):4326–4343PubMedCrossRef
20.
Ronnov-Jessen L, Bissell MJ (2009) Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med 15(1):5–13PubMedCrossRef
21.
Brower V (2010) Homing in on mechanisms linking breast density to breast cancer risk. J Natl Cancer Inst 102(12):843–845PubMedCrossRef
22.
Butcher DT, Alliston T, Weaver VM (2009) A tense situation: forcing tumour progression. Nat Rev Cancer 9(2):108–122PubMedCrossRef
Metadata
Title
Breast fat and breast cancer
Authors
Andreas Pettersson
Rulla M. Tamimi
Publication date
01-08-2012
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2186-2

Other articles of this Issue 1/2012

Breast Cancer Research and Treatment 1/2012 Go to the issue

Epidemiology

Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences

Clinical Trial

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer

Preclinical Study

Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation

Brief Report

Feature extraction via composite scoring and voting in breast cancer

Brief Report

PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer

Preclinical Study

Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits